Category: Pharmaceuticals

Pharmaceuticals

Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate

Two Phase 3 studies of Merck's investigational 15-valent pneumococcal conjugate vaccine met their primary immunogenicity objectives.

Pharmaceuticals

FDA Approves Abbreviated NDA for Sedation Drug

The FDA approved an abbreviated new drug application for dexmedetomidine hydrochloride in 0.9% sodium chloride injection, which is used for patient sedation in some medical procedures.

Pharmaceuticals

FDA Approves Nucala for Eosinophilic Granulomatosis with Polyangiitis

The FDA has approved Nucala (mepolizumab) as the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome.

Clinical Trials

COVID-19: Clinical Trial Starts for Remdesivir plus Interferon β1a

The National Institutes of Health has initiated a randomized, controlled clinical trial evaluating the safety and efficacy of the antiviral remdesivir (Gilead Sciences) plus the immunomodulator interferon beta-1a (Merck) in patients with COVID-19.

US Pharmaceuticals

Inhaled Nitric Oxide: A Potential Treatment for Severe COVID-19?

Inhaled nitric oxide has been used to treat pulmonary hypertension and ARDS for decades. Now, research is emerging on positive outcomes for critical care COVID-19 patients who have been treated with iNO.

Intl' Pharmaceuticals

Russia COVID-19 Vaccine Reportedly Tested on Just 76 Humans

The COVID-19 vaccine, known as 'Sputnik V' and developed by the Gamaleya Research Institute in Moscow, has reportedly been tested in just 76 humans.